Overview of nanoparticulate strategies for solubility enhancement of poorly soluble drugs

KU Khan, MU Minhas, SF Badshah, M Suhail, A Ahmad… - Life Sciences, 2022 - Elsevier
Poor aqueous solubility and poor bioavailability are major issues with many pharmaceutical
industries. By some estimation, 70–90% drug candidates in development stage while up-to …
被引用次数：126 相关文章

Overview of nanoparticulate strategies for solubility enhancement of poorly soluble drugs.

KU Khan, MU Minhas, SF Badshah, M Suhail… - Life …, 2022 - europepmc.org
Poor aqueous solubility and poor bioavailability are major issues with many pharmaceutical
industries. By some estimation, 70-90% drug candidates in development stage while up-to …

Overview of nanoparticulate strategies for solubility enhancement of poorly soluble drugs

KU Khan, MU Minhas, SF Badshah, M Suhail… - Life …, 2022 - pubmed.ncbi.nlm.nih.gov
Poor aqueous solubility and poor bioavailability are major issues with many pharmaceutical
industries. By some estimation, 70-90% drug candidates in development stage while up-to …

[引用][C] Overview of nanoparticulate strategies for solubility enhancement of poorly soluble drugs

KU Khan, MU Minhas, SF Badshah, M Suhail, A Ahmad… - 2022